A randomized, phase III trial comparing Busulfan-Cyclophosphamide and Busulfan-Fludarabine as a myeloablative conditioning regimen

Trial Profile

A randomized, phase III trial comparing Busulfan-Cyclophosphamide and Busulfan-Fludarabine as a myeloablative conditioning regimen

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Jun 2011

At a glance

  • Drugs Busulfan (Primary) ; Cyclophosphamide (Primary) ; Fludarabine (Primary)
  • Indications Acute lymphoblastic leukaemia; Acute myeloid leukaemia; Chronic lymphocytic leukaemia; Graft-versus-host disease; Myelodysplastic syndromes
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top